Heart Disease Risk Elevated in Rheumatoid Arthritis

Adults with rheumatoid arthritis face higher cardiovascular risks when immune and metabolic markers remain elevated.

Updated on Oct. 27, 2026 in Arthritis

Isometric editorial illustration featuring two glass test tubes with fluid gradients, representing clinical medical diagnostic markers.
New research shows that adults with rheumatoid arthritis face significantly higher cardiovascular risks when immune and metabolic health markers remain elevated. AI Illustration. Upload story photo >

Live Poll

Should doctors consider both metabolic health and inflammation when managing chronic conditions like arthritis?

New research identifies a link between combined immune-metabolic health and increased cardiovascular risk in patients with rheumatoid arthritis. The study tracks how chronic inflammation and glucose-lipid imbalances interact to influence heart health over time.

Why it matters

Rheumatoid arthritis is known to increase heart disease risk, but this research highlights how specific combinations of metabolic and immune factors can significantly amplify that danger. Understanding these markers helps clinicians better identify which patients may require more aggressive cardiovascular monitoring.

This cohort study followed 4,902 rheumatoid arthritis patients over a maximum of six years, recording 355 incident cardiovascular events. Participants with baseline dual-high immune-metabolic status showed a hazard ratio of 9.46 compared to the dual-low control group.

The details

Researchers utilized multistage nested Cox proportional hazards regression models to assess the combined impact of systemic inflammation and glucose-lipid metabolic abnormalities. Restricted cubic splines were applied to quantify nonlinear associations within the data. Findings indicated that both baseline and persistent dual-high status are significantly associated with higher cardiovascular disease risk in this population.

Timeline

  1. The study followed participants over a maximum period of 6 years.

Health Landscape

This research builds on the existing standard of care for rheumatoid arthritis by connecting immune status more directly to cardiac outcomes. It shifts the focus from managing inflammation in isolation to understanding how metabolic comorbidities create synergistic risks for heart disease.

If you are living with rheumatoid arthritis, it is worth discussing your cardiovascular risk profile and blood work with your rheumatologist. Ask how your current inflammation levels and metabolic markers might influence your long-term heart health plan.

The takeaway

Chronic immune and metabolic stressors are clear indicators of heightened cardiovascular risk in rheumatoid arthritis patients. Keep an open dialogue with your primary care team about monitoring your lipid and glucose levels alongside your inflammatory disease markers.

Further reading

Learn more about managing heart health and systemic inflammation in our Arthritis section.

More information

View the full results in the peer-reviewed research article.

Source note: This article includes information reported by Nature.

Live Poll

Should doctors consider both metabolic health and inflammation when managing chronic conditions like arthritis?